Upadacitinib (CAS 1310726-60-3)
« Back to Anti-Rheumatism API
Upadacitinib
CAS No. 1310726-60-3
乌帕替尼
Chemical structure
| CAS No. | 1310726-60-3 |
|---|---|
| Synonyms | (3S, 4R)-3-Ethyl-4-(3H-imidazo [1,2-a] pyrrole [2,3-e] pyrazine-8-yl)-N-(2,2,2-trifluoroethyl) pyrrolidine-1-formamide; ABT-494 |
| Category | Anti-Rheumatism API / Anti-Rheumatism |
| Assay / Purity | 99% |
| Molecular Formula | C17H19F3N6O |
| Molecular Weight | 380.4 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Upadacitinib is a JAK1-selective inhibitor supplied as the free base. It is used in oral extended-release tablets for rheumatoid arthritis, atopic dermatitis, psoriatic arthritis and axial spondyloarthritis. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 1310726-60-3 · PubChem CID 58557659